John G. Frelinger
- Immunology top 0.5%
- Immunotherapy and Immune Responses 38
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 20
- Oncology top 1%
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 8
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 13
-
- Monoclonal and Polyclonal Antibodies Research 17
- Biotechnology top 5%
-
- Glycosylation and Glycoproteins Research 11
- Co-authors
- Edith M. LordAmit A. LugadeScott A. GerberRobert C. RoseLeroy HoodRichard K. BarthElizabeth W. SorensenJeffrey A. Frelinger
- Journals
- The Journal of Immunology (9 papers)Immunogenetics (5 papers)European Journal of Immunology (5 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
John G. Frelinger
88 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology 2.5k
- Oncology 1.8k
- Immunology and Allergy 266
- Radiology, Nuclear Medicine and Imaging 604
- Biotechnology 155
Countries citing papers authored by John G. Frelinger
This map shows the geographic impact of John G. Frelinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Frelinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Frelinger more than expected).
Fields of papers citing papers by John G. Frelinger
This network shows the impact of papers produced by John G. Frelinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Frelinger. The network helps show where John G. Frelinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John G. Frelinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2019 | 21 | |
| 3 | Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpointsbreakdown → | 2015 | 380 |
| 4 | 2013 | 101 | |
| 5 | 2011 | 5 | |
| 6 | 2008 | 392 | |
| 7 | 2006 | 146 | |
| 8 | Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumorbreakdown → | 2005 | 775 |
| 9 | 2003 | 7 | |
| 10 | 2001 | 72 | |
| 11 | 2000 | 61 | |
| 12 | 1996 | 17 | |
| 13 | 1995 | 43 | |
| 14 | 1995 | 24 | |
| 15 | 1993 | 1 | |
| 16 | 1990 | 13 | |
| 17 | 1990 | 14 | |
| 18 | 1990 | 4 | |
| 19 | 1988 | 14 | |
| 20 | 1976 | 9 |
About John G. Frelinger
John G. Frelinger is a scholar working on Immunology, Immunology and Allergy, Oncology, Radiology, Nuclear Medicine and Imaging and Virology, having authored 88 papers that have together received 4.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (38 papers), Immune Cell Function and Interaction (23 papers), T-cell and B-cell Immunology (20 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cell Adhesion Molecules Research (13 papers), Glycosylation and Glycoproteins Research (11 papers), CAR-T cell therapy research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Immunology (2.5k citations), Oncology (1.8k citations), Immunology and Allergy (266 citations), Radiology, Nuclear Medicine and Imaging (604 citations) and Biotechnology (155 citations). John G. Frelinger has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Edith M. Lord, Amit A. Lugade, Scott A. Gerber, Robert C. Rose, Leroy Hood, Richard K. Barth, Elizabeth W. Sorensen, Jeffrey A. Frelinger, Scott A. Gerber and Julie R. Ostberg. Their work appears in journals such as The Journal of Immunology, Immunogenetics, European Journal of Immunology, Proceedings of the National Academy of Sciences and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.